ST Segment Elevation in COVID-19 Patients: Insights from Case Series

Myocardial injury with ST segment elevation is observed in patients with COVID-19, indicating potential cardiac involvement and emphasizing the need for cardiac monitoring and management in affected individuals to optimize clinical outcomes.

January 2021
ST Segment Elevation in COVID-19 Patients: Insights from Case Series

Myocardial injury with ST segment elevation has been observed in patients with coronavirus disease 2019 (Covid-19). Here, we describe our experience in the initial month of the Covid-19 outbreak in New York City.

Patients with confirmed Covid-19 who had ST-segment elevation on electrocardiography were included in the study from six New York hospitals.

Covid-19 patients who had non-obstructive disease on coronary angiography or had normal wall motion on echocardiography in the absence of angiography were presumed to have non-coronary myocardial injury.

We identified 18 patients with Covid-19 who had ST segment elevation, indicating possible acute myocardial infarction.

ST Segment Elevation in COVID-19 Patients: InsightExample, ECG patient 4

The median age of the patients was 63 years , 83% were men, and 33% had chest pain at the time of ST segment elevation.

A total of 10 patients (56%) had ST-segment elevation at presentation, and the other 8 patients developed ST-segment elevation during hospitalization (median, 6 days).

Of 14 patients (78%) with focal ST-segment elevation, 5 (36%) had a normal left ventricular ejection fraction , of whom 1 (20%) had a regional wall motion abnormality ; 8 patients (57%) had reduced left ventricular ejection fraction , of whom 5 (62%) had regional wall motion abnormalities . (One patient did not have an echocardiogram).

Of the 4 patients (22% of the general population) with diffuse ST-segment elevation, 3 (75%) had a normal left ventricular ejection fraction and normal wall motion; 1 patient had a left ventricular ejection fraction of 10% with global hypokinesia.

A total of 9 patients (50%) underwent coronary angiography ; 6 of these patients (67%) had obstructive disease and 5 (56%) underwent percutaneous coronary intervention (1 after administration of fibrinolytic agents).

The 8 patients (44%) who received a clinical diagnosis of myocardial infarction had higher mean troponin and d-dimer levels than the 10 patients (56%) with noncoronary myocardial injury.

A total of 13 patients (72%) died in the hospital (4 patients with myocardial infarction and 9 with non-coronary myocardial injury).

In this series of Covid-19 patients who had ST segment elevation, there was variability in presentation, a high prevalence of non-obstructive disease, and a poor prognosis.

Half of the patients underwent coronary angiography, of whom two-thirds had obstructive disease.

Of note, all 18 patients had elevated d-dimer levels . In contrast, in a previous study involving patients who presented with ST-segment elevation myocardial infarction, 64% had normal d-dimer levels.

Timing of ST segment elevation, length of stay, and outcome

ST Segment Elevation in COVID-19 Patients: InsightNote that coronary angiography with or without PCI at the time of ST elevations (except patient 5). Patient no. Patient #5 received thrombolytic therapy at the time of ST segment elevation and underwent PCI one day later.

  • Myocardial injury in patients with Covid-19 could be due to plaque rupture, cytokine storm, hypoxic injury, coronary spasm, microthrombi, or direct endothelial or vascular injury.
     
  • Myocardial interstitial edema has been demonstrated on MRI in such patients.